Davis Gates

714 total citations
28 papers, 445 citations indexed

About

Davis Gates is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Davis Gates has authored 28 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 12 papers in Immunology and Allergy and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Davis Gates's work include Asthma and respiratory diseases (17 papers), Allergic Rhinitis and Sensitization (12 papers) and Respiratory and Cough-Related Research (10 papers). Davis Gates is often cited by papers focused on Asthma and respiratory diseases (17 papers), Allergic Rhinitis and Sensitization (12 papers) and Respiratory and Cough-Related Research (10 papers). Davis Gates collaborates with scholars based in United States, United Kingdom and Canada. Davis Gates's co-authors include Keith Gordon, Georg Griesinger, Barbara J. Stegmann, Paul E. Verweij, Eric Schenkel, Basil C. Tarlatzis, Paul Devroey, Ariel Teper, Robert Anolik and Hendrik Nolte and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and The Journal of Urology.

In The Last Decade

Davis Gates

27 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davis Gates United States 15 195 146 123 118 110 28 445
AM Abou-Setta Canada 6 86 0.4× 21 0.1× 166 1.3× 177 1.5× 35 0.3× 7 382
Kai Håkon Carlsen Norway 12 300 1.5× 70 0.5× 44 0.4× 1 0.0× 224 2.0× 16 484
Stephen E. Helms United States 11 19 0.1× 20 0.1× 66 0.5× 9 0.1× 12 0.1× 25 293
Johannes Martin Schmid Denmark 13 325 1.7× 300 2.1× 31 0.3× 128 1.2× 43 504
Deirdre Vincent Germany 10 22 0.1× 14 0.1× 88 0.7× 7 0.1× 73 0.7× 22 305
Filomenamila Lorusso Italy 15 12 0.1× 9 0.1× 162 1.3× 419 3.6× 13 0.1× 31 579
Carole Langlois‐Jacques France 10 109 0.6× 2 0.0× 97 0.8× 32 0.3× 82 0.7× 23 543
Denisa Ferastraoaru United States 11 124 0.6× 149 1.0× 10 0.1× 90 0.8× 37 504
Amy S. Feldman United States 4 133 0.7× 19 0.1× 28 0.2× 5 0.0× 124 1.1× 4 321
Pramod S. Kelkar United States 7 68 0.3× 85 0.6× 56 0.5× 84 0.8× 9 356

Countries citing papers authored by Davis Gates

Since Specialization
Citations

This map shows the geographic impact of Davis Gates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davis Gates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davis Gates more than expected).

Fields of papers citing papers by Davis Gates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davis Gates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davis Gates. The network helps show where Davis Gates may publish in the future.

Co-authorship network of co-authors of Davis Gates

This figure shows the co-authorship network connecting the top 25 collaborators of Davis Gates. A scholar is included among the top collaborators of Davis Gates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davis Gates. Davis Gates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaoli, Tulin Shekar, Davis Gates, et al.. (2020). Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy. The Journal of Allergy and Clinical Immunology In Practice. 8(5). 1634–1644.e1. 1 indexed citations
2.
Arrieta, Antonio, Lillian Sung, John S. Bradley, et al.. (2019). A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia. PLoS ONE. 14(3). e0212837–e0212837. 34 indexed citations
3.
Shekar, Tulin, et al.. (2018). Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate. Journal of Allergy and Clinical Immunology. 143(4). 1395–1402. 17 indexed citations
4.
Urdaneta, Elena, Kaan Tunceli, & Davis Gates. (2018). Mometasone Furoate Nasal Spray Relieves Moderate-Severe Nasal Congestion in Patients with Seasonal Allergic Rhinitis: A Responder Analysis. Journal of Allergy and Clinical Immunology. 141(2). AB68–AB68.
5.
Peloso, Paul M., R Andrew Moore, Wen‐Jer Chen, et al.. (2016). Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial. Scandinavian Journal of Pain. 13(1). 175–181. 10 indexed citations
6.
Boostanfar, R., et al.. (2016). Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial. Fertility and Sterility. 106(2). 300–305.e5. 5 indexed citations
7.
Griesinger, Georg, Paul E. Verweij, Davis Gates, et al.. (2016). Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol. PLoS ONE. 11(3). e0149615–e0149615. 65 indexed citations
8.
Rombauts, Luk, Cornelis B. Lambalk, A. Schultze-Mosgau, et al.. (2015). Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol. Fertility and Sterility. 104(4). 884–890.e2. 25 indexed citations
9.
Máspero, Jorge, Iván Chérrez-Ojeda, Dennis E. Doherty, et al.. (2014). Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma. Respiratory Medicine. 108(9). 1355–1362. 5 indexed citations
10.
Meltzer, Eli O., Carlos E. Baena‐Cagnani, Davis Gates, & Ariel Teper. (2013). Relieving nasal congestion in children with seasonal and perennial allergic rhinitis: efficacy and safety studies of mometasone furoate nasal spray. World Allergy Organization Journal. 6(1). 5–5. 11 indexed citations
11.
Nolte, Hendrik, Ian Pavord, Vibeke Backer, et al.. (2013). Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma. Respiratory Medicine. 107(5). 656–664. 26 indexed citations
12.
Bernstein, David I., Ariel Teper, Gokul Gopalan, & Davis Gates. (2012). Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis. Annals of Allergy Asthma & Immunology. 108(5). 359–362. 6 indexed citations
13.
Greenberg, Steven, Nancy Liu, Amarjot Kaur, et al.. (2012). The Asthma Disease Activity Score: A discriminating, responsive measure predicts future asthma attacks. Journal of Allergy and Clinical Immunology. 130(5). 1071–1077.e10. 15 indexed citations
14.
Meltzer, Eli O., Davis Gates, & Claus Bachert. (2012). Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis. Annals of Allergy Asthma & Immunology. 108(4). 275–279. 14 indexed citations
15.
Wyrwich, Kathleen W., Andrea M. Ireland, Prakash Navaratnam, Hendrik Nolte, & Davis Gates. (2010). An Assessment of Change in Asthma Control among Adolescents and Adults with Persistent Asthma In Mometasone Furoate/Formoterol Fumarate Clinical Trials. Journal of Asthma. 48(1). 48–56. 4 indexed citations
16.
Wyrwich, Kathleen W., Andrea M. Ireland, Prakash Navaratnam, Hendrik Nolte, & Davis Gates. (2010). Validation of the AQLQ12+ among adolescents and adults with persistent asthma. Quality of Life Research. 20(6). 903–912. 2 indexed citations
17.
Wyrwich, Kathleen W., Sajjad Khan, Prakash Navaratnam, Hendrik Nolte, & Davis Gates. (2010). Validation and agreement across four versions of the asthma control questionnaire in patients with persistent asthma. Respiratory Medicine. 105(5). 698–712. 14 indexed citations
18.
Anolik, Robert, David S. Pearlman, Ariel Teper, & Davis Gates. (2009). Mometasone furoate improves nasal and ocular symptoms of seasonal allergic rhinitis in adolescents. Allergy and Asthma Proceedings. 30(4). 406–412. 20 indexed citations
19.
Anolik, Robert, Robert A. Nathan, Eric Schenkel, et al.. (2008). Intranasal Mometasone Furoate Alleviates the Ocular Symptoms Associated with Seasonal Allergic Rhinitis: Results of a Post Hoc Analysis. International Archives of Allergy and Immunology. 147(4). 323–330. 20 indexed citations
20.
Salmun, Luis M., et al.. (2000). Loratadine versus cetirizine: Assessment of somnolence and motivation during the workday. Clinical Therapeutics. 22(5). 573–582. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026